Clinical updates, including data readouts and publications: Aspire, Abbvie, Artelo, Genmab, Merck, Splisense, Valneva, Wave Life Sciences.

Clinical updates, including data readouts and publications: Alnylam, Amarin, AMI, Biogen, Bridgebio, Compass,Cytokinetics, Eupraxia, Grin, Ionis, Lexicon, Merck, Novartis, Oncolytics, Roche, United Therapeutics, Upstream, Zymeworks.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Brightheart, First Ascent, Iantrek, Inflammatix, Zoll.

Clinical updates, including data readouts and publications: Beone, Exelixis, Johnson & Johnson, Zydus.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Correctseqeuence Therapeutics.

Clinical updates, including data readouts and publications: Ascletis, Prothena.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Orchestra Biomed; Peytant; Veracyte.

Clinical updates, including data readouts and publications: Antiva, Bioxcel, Eli Lilly, Moleculin, Remegen, Vor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Resmed.

Clinical updates, including data readouts and publications: Correctsequence, Eli Lilly, Jcyte, Marker, Regeneron.